Integrated DNA Technologies is launching a new suite of next-generation sequencing products designed to address persistent bottlenecks in cancer research workflows, the genomics company announced.

The new portfolio includes the DNA EZ v2 Library Preparation Kit, the xGen Exome v2 Hyb Spike-In Panel, an expanded set of 1,536 Full-Length Unique Dual Index adapters, and an enhanced whole genome sequencing system. IDT said the products are designed to simplify sequencing workflows, improve variant identification and support broader biomarker discovery.

Central to the release is an advanced fragmentation module engineered to reduce GC-related bias and minimize fragmentation-induced artifacts during library construction — two longstanding challenges in the field. The technology is designed to support transitions between whole genome and targeted sequencing, allowing researchers to unify workflows across tumor-informed profiling and minimal residual disease applications.

The expanded exome panel broadens genomic coverage and aligns with major scientific databases to strengthen variant classification. The enhanced whole genome sequencing system delivers full-genome analysis alongside enriched coverage of targeted regions within a single assay, supporting identification of germline and somatic variants, structural variations and genomic instability markers.

“These transformative updates to IDT’s NGS innovation roadmap will deliver greater precision, higher throughput, and adaptable workflows for translational and clinical research applications,” said Ajay Gannerkote, IDT president. “These purpose-built innovations are made possible by IDT’s specialized, high-throughput production and history of sustained innovation.”

IDT is part of Danaher, a global science and technology leader. More information on the new products is available at idtdna.com.